Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Fundamental data now powered by FactSet with hourly updates!

FLGT | Fulgent Genetics Inc

IndexRUT P/E- EPS (ttm)-1.64 Insider Own36.44% Shs Outstand29.44M Perf Week-4.92%
Market Cap827.56M Forward P/E- EPS next Y-0.84 Insider Trans-0.22% Shs Float19.02M Perf Month-17.49%
Income-48.68M PEG- EPS next Q-0.32 Inst Own46.53% Short Float / Ratio3.14% / 2.86 Perf Quarter-25.59%
Sales307.38M P/S2.69 EPS this Y- Inst Trans1.28% Short Interest0.60M Perf Half Y-11.15%
Book/sh42.11 P/B0.66 EPS next Y11.52% ROA-3.46% Target Price45.00 Perf Year-27.67%
Cash/sh15.32 P/C1.81 EPS next 5Y15.14% ROE-3.80% 52W Range27.30 - 44.09 Perf YTD-7.15%
Dividend- P/FCF21.91 EPS past 5Y- ROI-3.83% 52W High-37.29% Beta1.56
Dividend %- Quick Ratio8.15 Sales past 5Y272.11% Gross Margin29.45% 52W Low1.28% ATR0.87
Employees1012 Current Ratio8.15 Sales Q/Q-45.87% Oper. Margin-26.27% RSI (14)19.10 Volatility2.67% 2.50%
OptionableYes Debt/Eq0.02 EPS Q/Q- Profit Margin-15.84% Rel Volume0.92 Prev Close27.32
ShortableYes LT Debt/Eq0.01 EarningsAug 04 BMO Payout0.00% Avg Volume208.89K Price27.65
Recom2.00 SMA20-10.25% SMA50-19.40% SMA200-18.07% Volume191,874 Change1.21%
Date Action Analyst Rating Change Price Target Change
Dec-08-22Downgrade Piper Sandler Overweight → Neutral $65 → $40
Nov-18-22Initiated Raymond James Outperform $45
Aug-25-22Initiated Credit Suisse Outperform $65
Feb-04-22Resumed Piper Sandler Overweight $80
Aug-05-21Resumed Credit Suisse Underperform $55
Jan-08-21Downgrade Credit Suisse Neutral → Underperform $42 → $40
Nov-24-20Downgrade BTIG Research Buy → Neutral
Aug-20-20Initiated Oppenheimer Outperform $75
May-29-20Initiated BTIG Research Buy $20
Nov-05-19Upgrade Piper Jaffray Neutral → Overweight
Nov-07-17Downgrade Raymond James Outperform → Mkt Perform
Aug-05-23 08:56AM
Aug-04-23 10:08PM
Jul-24-23 04:05PM
08:00AM Loading…
Jul-18-23 08:00AM
Jun-21-23 08:00PM
Jun-14-23 11:40AM
Jun-06-23 07:45AM
Jun-05-23 08:30AM
May-23-23 09:53AM
May-18-23 04:05PM
May-08-23 11:15AM
08:15AM Loading…
May-05-23 08:15AM
Apr-26-23 08:00PM
Apr-20-23 04:05PM
Apr-16-23 02:01PM
Apr-14-23 07:13AM
Apr-12-23 09:40AM
Apr-11-23 08:00AM
Mar-27-23 09:40AM
Mar-24-23 03:54PM
Mar-09-23 09:40AM
Mar-04-23 07:50AM
Mar-03-23 11:17AM
Mar-01-23 10:13AM
08:25PM Loading…
Feb-28-23 08:25PM
Feb-26-23 09:05AM
Feb-23-23 04:05PM
Feb-14-23 04:05PM
Feb-03-23 05:18AM
Jan-03-23 04:05PM
Dec-15-22 08:11AM
Dec-02-22 12:08PM
Nov-24-22 10:30AM
Nov-17-22 04:05PM
Nov-16-22 06:52AM
Nov-09-22 08:02AM
Nov-07-22 05:55PM
Oct-26-22 07:54AM
Oct-25-22 04:03PM
Oct-20-22 04:03PM
Oct-10-22 11:31AM
Aug-26-22 07:22AM
Aug-25-22 12:10PM
Aug-23-22 02:03PM
Aug-06-22 05:00AM
Aug-05-22 06:30AM
Aug-04-22 07:25PM
Jul-25-22 06:15PM
Jul-19-22 08:00AM
Jul-14-22 06:17PM
Jul-11-22 09:46AM
Jul-05-22 08:00AM
Jun-29-22 06:15PM
Jun-21-22 06:15PM
Jun-19-22 09:06AM
Jun-04-22 08:06AM
May-19-22 07:04AM
May-17-22 11:30AM
May-03-22 11:30PM
Apr-28-22 10:15AM
Apr-27-22 12:05PM
Apr-25-22 06:05PM
Apr-22-22 11:23AM
Apr-18-22 04:05PM
Apr-08-22 07:55AM
Apr-05-22 04:41PM
Mar-18-22 10:23AM
Mar-16-22 10:28AM
Mar-15-22 05:41PM
Mar-12-22 10:45AM
Mar-08-22 08:00AM
Mar-07-22 08:00AM
Mar-06-22 07:37AM
Feb-24-22 09:00AM
Feb-23-22 11:00PM
Feb-21-22 10:37AM
Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded by Ming Hsieh on May 13, 2016 and is headquartered in El Monte, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Xie JianPresident and COOSep 07Sale31.411,49246,861416,022Sep 11 04:37 PM
Kim PaulCFO and TreasurerSep 07Sale31.411,49246,861214,061Sep 11 04:35 PM
Gao HanlinChief Scientific OfficerSep 07Sale31.411,04132,696912,932Sep 11 04:34 PM
Kim PaulCFO and TreasurerAug 28Sale33.6210,299346,297215,553Aug 30 04:54 PM
Kim PaulCFO and TreasurerAug 17Sale33.881,79860,918225,852Aug 21 04:40 PM
Xie JianPresident and COOAug 17Sale33.881,30744,283417,514Aug 21 04:43 PM
Gao HanlinChief Scientific OfficerAug 17Sale33.8834211,587913,973Aug 21 04:34 PM
Xie JianPresident and COOJun 02Sale40.301,43357,744425,794Jun 06 05:11 PM
Kim PaulCFO and TreasurerJun 02Sale40.301,40356,535228,890Jun 06 05:09 PM
Gao HanlinChief Scientific OfficerJun 02Sale40.301,00040,296914,391Jun 06 05:06 PM
Xie JianPresident and COOMay 17Sale35.461,32046,810427,227May 19 04:23 PM
Kim PaulCFO and TreasurerMay 17Sale35.461,26644,895230,293May 19 04:19 PM
Gao HanlinChief Scientific OfficerMay 17Sale35.4634512,234915,391May 19 04:15 PM
KIM PAULCFO and TreasurerDec 02Sale35.3365323,070223,403Dec 06 04:42 PM
Xie JianPresident and COONov 30Sale34.3968523,559430,074Dec 02 05:07 PM
KIM PAULCFO and TreasurerNov 16Sale35.891,79664,460224,056Nov 18 04:13 PM
Xie JianPresident and COONov 16Sale35.891,30646,873430,759Nov 18 04:20 PM
Gao HanlinChief Scientific OfficerNov 16Sale35.8934212,275906,585Nov 18 04:12 PM